Biotechnology - Unlock the Power of Epigenetics with direct Whole Methylome Sequencing! |
|
|
|
|
|
|
The latest Biotechnology news from AZoNetwork |
|
|
|
| |
Pittcon 2025 Comes to Boston
As a global biotech hub and home to prestigious academic and research institutions, Boston is the ideal setting for Pittcon 2025—your opportunity to forge invaluable biotech connections.
| |
|
|
|
|
| | The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year. | | | | Herbal medicine is difficult to produce on an industrial scale. A team of Kobe University bioengineers manipulated the cellular machinery in a species of yeast so that one such molecule can now be produced in a fermenter at unprecedented concentrations. | | | | A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) ⎯ a potent immune-boosting protein that holds promise for cancer treatment ⎯ loses effectiveness over time when used as an immunotherapeutic. | | | | Researchers from the UCLA Samueli School of Engineering and the University of Rome Tor Vergata in Italy have developed synthetic genes that function like the genes in living cells. | | | | Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to the cartilage and bone. | | | | Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for essential drugs, making the process quicker, more efficient, and environmentally friendly. | | | | Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. | |
|
|
|
|
| How would you rate today's newsletter?
| |
|
|
|
| |
|
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|